We are live on
!
Find out more
KXA
KPCB XIII Associates Portfolio holdings
AUM
$186M
1-Year Est. Return
11.23%
This Fund
S&P 500
This Quarter
Est. Return
-14.87%
1 Year Est. Return
-11.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$38M
(-17%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.5% |
| 2 | Technology | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progyny
PGNY
$2.49B
| $173M | 92.97% |
5,074,615
| – | – |
|
2
Pulmonx
LUNG
$57.2M
| $10.3M | 5.53% |
994,971
| – | – |
|
|
MVLA
3
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $2.78M | 1.5% |
5,189,011
| – | – |
|
Similar funds
BC
CC
BAG
SWA
DLG
NFAM
RCGI
TA
KPCB XIII Associates's Q3 2023 Portfolio in Review
As of Q3 2023, KPCB XIII Associates held 3 positions worth $186M, down 17% from $224M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 0%. KPCB XIII Associates opened no new positions and made no exits, leaving the 3-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 95% a quarter earlier, followed by Technology.
- KPCB XIII Associates's ten largest holdings make up 100% of its $186M portfolio in Q3 2023.
- KPCB XIII Associates opened 0 new positions and closed 0 in Q3 2023.
- KPCB XIII Associates's portfolio value fell 17% quarter-over-quarter to $186M.
Based on KPCB XIII Associates's 13F filing for Q3 2023, filed 8 Nov 2023.